← FDA Drug Approvals (Drugs@FDA)
PROGESTERONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-01-05
Drug application
- FDA Application #
ANDA215634- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PROGESTERONE
- Generic name
- PROGESTERONE
- Active ingredients
- PROGESTERONE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- XIROMED, LLC
- First approval
- 2022-01-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown